Do GLP-1 drugs (like Ozempic) boost male fertility

Majority view

Current evidence does not show that GLP-1 drugs are established fertility‑boosting treatments for men, but small studies and recent reviews indicate they can improve some male fertility markers (such as testosterone and sperm parameters) in men with obesity or metabolic dysfunction, mainly via weight loss and related hormonal normalization, without clear evidence of harm.[2][3][4][5][9][11][13][14][15][16] Major clinical guidelines do not yet endorse GLP‑1 agonists as male fertility therapies, and experts emphasize that data are limited and heterogeneous, so any beneficial effect should be viewed as possible and context‑dependent rather than proven or generalizable to all men.[2][3][4][5][6][9][14][15][16]

Credible dissent

Authoritative reviews and expert commentaries state that direct effects of GLP‑1 agonists on male fertility remain largely unexplored, and emphasize the lack of robust, long‑term human data.[2][3][5][6][14][15] Some clinicians and commentators warn that rapid weight loss associated with these drugs can coincide with reduced testosterone or semen quality in some men, and stress that GLP‑1 agonists should not be used as fertility medications.[4][7][10] Other recent conference reports and narrative reviews suggest that GLP‑1 receptor agonists are unlikely to harm fertility and may improve sperm parameters and testosterone in obese hypogonadal men, leading to optimism about a beneficial effect.[11][13][14][15][1] This mix of cautious and more positive interpretations of limited data constitutes substantial, good‑faith dissent about whether GLP‑1 drugs truly "boost" male fertility in a broad sense.